Search Results - "Mollgard, Lars"

Refine Results
  1. 1

    Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry by Juliusson, Gunnar, Antunovic, Petar, Derolf, Åsa, Lehmann, Sören, Möllgård, Lars, Stockelberg, Dick, Tidefelt, Ulf, Wahlin, Anders, Höglund, Martin

    Published in Blood (2009)
    “…Acute myeloid leukemia (AML) is most common in the elderly, and most elderly are thought to be unfit for intensive treatment because of the risk of fatal…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    NOX2‐dependent immunosuppression in chronic myelomonocytic leukemia by Aurelius, Johan, Hallner, Alexander, Werlenius, Olle, Riise, Rebecca, Moüllgård, Lars, Brune, Mats, Hansson, Markus, Martner, Anna, Thorén, Fredrik B., Hellstrand, Kristoffer

    Published in Journal of leukocyte biology (01-08-2017)
    “…Human primary CMML cells produce immunosuppressive ROS that may impact on NK cell‐ and T cell‐mediated clearance of leukemic cells. Chronic myelomonocytic…”
    Get full text
    Journal Article
  6. 6

    The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting by Juliusson, Gunnar, Jädersten, Martin, Deneberg, Stefan, Lehmann, Sören, Möllgård, Lars, Wennström, Lovisa, Antunovic, Petar, Cammenga, Jörg, Lorenz, Fryderyk, Ölander, Emma, Lazarevic, Vladimir Lj, Höglund, Martin

    Published in Blood advances (24-03-2020)
    “…In acute myeloid leukemia (AML) FLT3 internal tandem duplication (ITD) and nucleophosmin 1 (NPM1) mutations provide prognostic information with clinical…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Prognostic significance of high hyperdiploid and triploid/tetraploid adult acute myeloid leukemia by Lazarevic, Vladimir, Rosso, Aldana, Juliusson, Gunnar, Antunovic, Petar, Rangert‐Derolf, Åsa, Lehmann, Sören, Möllgård, Lars, Uggla, Bertil, Wennström, Lovisa, Wahlin, Anders, Höglund, Martin, Johansson, Bertil

    Published in American journal of hematology (01-09-2015)
    “…To ascertain the clinical implications of high hyperdiploid (HH; 49–65 chromosomes) and triploid/tetraploid (TT; >65 chromosomes) adult acute myeloid leukemia…”
    Get full text
    Journal Article
  14. 14

    Prevalence and Characteristics of Survivors from Adult Acute Myeloid Leukemia (AML) in Sweden 2014 by Juliusson, Gunnar, Lazarevic, Vladimir, Antunovic, Petar, Derolf, Asa Rangert, Garelius, Hege, Lehmann, Sören, Myhr-Eriksson, Kristina, Möllgård, Lars, Uggla, Bertil, Wahlin, Anders, Wennström, Lovisa, Höglund, Martin

    Published in BLOOD (03-12-2015)
    “…The prevalence of survivors of adult AML has previously been calculated, but the prevalent population has not been characterized. We analysed all 6289 patients…”
    Get full text
    Journal Article Conference Proceeding
  15. 15
  16. 16

    Improved Survival of Patients with Acute Myeloid Leukemia Following Implementation of Swedish National Guidelines: Results from the AML Registry 1997-2013 by Juliusson, Gunnar, Lazarevic, Vladimir, Lehmann, Sören, Derolf, Åsa Rangert, Möllgård, Lars, Garelius, Hege, Wennström, Lovisa, Uggla, Bertil, Antunovic, Petar, Myhr-Eriksson, Kristina, Wahlin, Anders, Höglund, Martin

    Published in BLOOD (06-12-2014)
    “…Despite improved diagnostics and better understanding of AML biology, the basic chemotherapy has remained unchanged for decades, with no progress in outcome…”
    Get full text
    Journal Article Conference Proceeding
  17. 17
  18. 18
  19. 19

    Allogeneic Transplantation in First Remission Improves Outcome in Secondary Acute Myeloid Leukemia by Nilsson, Christer, Hulegårdh, Erik, Lazarevic, Vladimir, Garelius, Hege, Derolf, Asa Rangert, Möllgård, Lars, Wennström, Lovisa, Uggla, Bertil, Antunovic, Petar, Myhr-Eriksson, Kristina, Wahlin, Anders, Höglund, Martin, Juliusson, Gunnar, Stockelberg, Dick, Soren, Lehmann

    Published in BLOOD (2014)
    “…Allogeneic stem cell transplantation (SCT) is widely used as post-remission treatment in younger patients with poor or intermediate risk AML. Transplant…”
    Get full text
    Journal Article Conference Proceeding
  20. 20